Cyclo
streptin (FR182877), a bacterial natural product, wa
s reported to have weak paclitaxel-like activity with tubulin but antitumor activity in vivo. We u
sed
synthetic cyclo
streptin in
studie
s of it
smechani
sm of action. Although le
ss potent than paclitaxel in
several human cancer cell line
s, cyclo
streptinwa
s active again
st cell
s re
si
stant to paclitaxel and epothilone A. At equitoxic concentration
s with paclitaxel,cyclo
streptin wa
s more effective in arre
sting MCF-7 cell
s in mito
si
s and equivalent in bundling microtubule
sin PtK
2 cell
s. Tubulin a
ssembly with paclitaxel occur
s at low temperature
s and in the ab
sence of GTP ormicrotubule-a
ssociated protein
s (MAP
s). Bri
sk a
ssembly with cyclo
streptin required MAP
s, GTP, andhigher reaction temperature
s. On the ba
si
s of turbidimetry, cyclo
streptin-induced microtubule
s were more
stable in the cold than the paclitaxel-induced polymer. Moreover, at 37
![](/image<font color=)
s/entitie
s/deg.gif">C cyclo
streptin wa
s a
strongcompetitive inhibitor of the binding of radiolabeled paclitaxel to tubulin polymer, with an apparent
Kivalue of 88 nM. Competition
studie
s ver
su
s a fluore
scent taxoid acro
ss a temperature range, in compari
sonwith paclitaxel and docetaxel,
showed that only the binding of cyclo
streptin to microtubule
s wa
s markedlyreduced at 4
![](/image<font color=)
s/entitie
s/deg.gif">C ver
su
s temperature
s over 30
![](/image<font color=)
s/entitie
s/deg.gif">C. The binding of cyclo
streptin to microtubule
s wa
scharacterized by a relatively greater endothermic and entropic profile a
s compared with tho
se of the taxoidbinding reaction
s, which are characterized more by exothermic and enthalpic interaction
s. Molecularmodeling
showed that cyclo
streptin formed a pharmacophore with taxoid
s but formed hydrogen bond
sonly with the S9-S10 and M loop
s in the taxoid
site. Initial
studie
s al
so indicate that, relative to paclitaxel,cyclo
streptin i
s more deficient in nucleation than elongation of polymer.